HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angeliki Chroni Selected Research

HDL Cholesterol

1/2022Genetics and regulation of HDL metabolism.
12/2020Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
1/2020Structural and functional basis for increased HDL-cholesterol levels due to the naturally occurring V19L mutation in human apolipoprotein A-I.
1/2019HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling.
11/2015Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
8/2006Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angeliki Chroni Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2008
8Neuroblastoma
01/2021 - 11/2010
8Atherosclerosis
12/2020 - 04/2004
8Dyslipidemias (Dyslipidemia)
01/2015 - 08/2004
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 10/2011
5Hypertriglyceridemia
01/2014 - 04/2004
3Hypercholesterolemia
01/2022 - 03/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
12/2020 - 07/2011
3Lipoprotein Glomerulopathy
12/2018 - 01/2013
2Wounds and Injuries (Trauma)
01/2019 - 01/2018
2Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2014 - 01/2011
2Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency)
06/2011 - 11/2005
2Tangier Disease
08/2006 - 04/2004
2Coinfection
11/2005 - 08/2004
1Adenocarcinoma
01/2020
1Stab Wounds (Stab Wound)
01/2019
1Brain Injuries (Brain Injury)
01/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2019
1Ischemic Stroke
01/2019
1Stroke (Strokes)
01/2019
1Inflammation (Inflammations)
01/2018
1Amyloidosis
11/2015
1Ankylosing Spondylitis
09/2015
1Kidney Diseases (Kidney Disease)
04/2014
1Rare Diseases (Rare Disease)
04/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2011
1Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
08/2006
1Hyperlipidemias (Hyperlipidemia)
03/2005

Drug/Important Bio-Agent (IBA)

12Apolipoproteins E (ApoE)IBA
01/2022 - 04/2004
12Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2020 - 04/2004
9Lipoproteins (Lipoprotein)IBA
01/2022 - 01/2011
9Apolipoprotein E4IBA
01/2021 - 09/2008
8ApolipoproteinsIBA
01/2019 - 04/2006
7LipidsIBA
01/2022 - 04/2006
6HDL CholesterolIBA
01/2022 - 08/2006
6Apolipoprotein E3IBA
01/2022 - 01/2011
6CholesterolIBA
01/2019 - 04/2004
6Protein Isoforms (Isoforms)IBA
12/2018 - 11/2010
4HDL LipoproteinsIBA
01/2019 - 08/2004
4Peptides (Polypeptides)IBA
01/2019 - 05/2014
4Amyloid (Amyloid Fibrils)IBA
01/2018 - 11/2010
4Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2010
3AntioxidantsIBA
01/2020 - 06/2011
2LigandsIBA
01/2019 - 01/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 05/2014
2Triglycerides (Triacylglycerol)IBA
01/2014 - 03/2005
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
07/2011 - 08/2004
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2011 - 03/2005
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2006 - 04/2004
1Coloring Agents (Dyes)IBA
01/2022
1Evans Blue (Blue, Evans)FDA Link
01/2022
1PhenolsIBA
01/2021
1Lipoxygenase (Lipoxygenase-1)IBA
01/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2019
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2018
1cellulose synthaseIBA
01/2018
1Phosphatidic Acids (Phosphatidic Acid)IBA
01/2018
1EnzymesIBA
01/2018
1Complement System Proteins (Complement)IBA
01/2018
1Complement Factor H (Factor H)IBA
01/2018
1Fatty Acids (Saturated Fatty Acids)IBA
10/2017
1Monoclonal AntibodiesIBA
01/2015
1Amino AcidsFDA Link
04/2014
1LDL Receptors (LDL Receptor)IBA
01/2011
1Biological ProductsIBA
01/2008
1Phospholipid Transfer ProteinsIBA
01/2008
1TransferasesIBA
01/2008
1LecithinsIBA
01/2008
1Adenosine Triphosphate (ATP)IBA
01/2008
1oxidized low density lipoproteinIBA
03/2005
1Phospholipids (Phosphatides)FDA LinkGeneric
03/2005
1Glutamic Acid (Glutamate)FDA Link
08/2004
1Alanine (L-Alanine)FDA Link
08/2004

Therapy/Procedure

2Therapeutics
01/2015 - 07/2011